Literature DB >> 18093784

Simultaneous determination and pharmacokinetics of five bufadienolides in rat plasma after oral administration of Chansu extract by SPE-HPLC method.

Yan Liang1, Ai-hua Liu, Song Qin, Jiang-hao Sun, Min Yang, Ping Li, De-an Guo.   

Abstract

A sensitive and rapid solid-phase extraction-high performance liquid chromatography (SPE-HPLC) method has been developed for the determination of five bufadienolides, arenobufagin, teliocinobufagin, cinobufotalin, cinobufagin and resibufogenin in rat plasma and applied to a pharmacokinetic study in rats after oral administration of Chansu extract (Venenum Bufonis). Plasma samples were pretreated with solid-phase extraction using Extract-Clean cartridges, and the extracts were analyzed by a reversed-phase C(18) column on a HPLC system with photodiode array detection (DAD). The calibration curves were linear over the range of 0.10-1.66 microg/ml for arenobufagin, 0.03-1.20 microg/ml for telocinobufagin, 0.01-0.62 microg/ml for cinobufotalin, 0.03-0.70 microg/ml for cinobufagin and 0.02-2.57 microg/ml for resibufogenin, respectively. The limit of quantification was 1.1 ng/ml for arenobufagin, 0.3 ng/ml for telocinobufagin, 9.7 ng/ml for cinobufotalin, 8.8 ng/ml for cinobufagin, 7.7 ng/ml for resibufogenin, respectively. The established method could be easily applied to the determination and pharmacokinetic studies of five bufadienolides in rat plasma after oral administration of Chansu extract.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093784     DOI: 10.1016/j.jpba.2007.11.001

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Effect of arenobufagin on human pancreatic carcinoma cells.

Authors:  Tianjiao Wang; Zhumei Zhuang; Peng Zhang; Yueyue Wang; Lin Mu; Haifeng Jin; Lei Zhou; Xiaochi Ma; Rui Liang; Yuhui Yuan
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

2.  Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling.

Authors:  Syeda H Afroze; Jenna Sloan; Grace-Ann C Osuji; Nathan Drever; Kimberly Pilkinton; David C Zawieja; Thomas J Kuehl; M Nasir Uddin
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

3.  The effects of bufadienolides on HER2 overexpressing breast cancer cells.

Authors:  Tianjiao Wang; Lin Mu; Haifeng Jin; Peng Zhang; Yueyue Wang; Xiaochi Ma; Jinjin Pan; Jian Miao; Yuhui Yuan
Journal:  Tumour Biol       Date:  2015-12-12

4.  TXNIP/TRX/NF-κB and MAPK/NF-κB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats.

Authors:  Qi-Rui Bi; Jin-Jun Hou; Peng Qi; Chun-Hua Ma; Rui-Hong Feng; Bing-Peng Yan; Jian-Wei Wang; Xiao-Jian Shi; Yuan-Yuan Zheng; Wan-Ying Wu; De-An Guo
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

5.  Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice.

Authors:  Zhaoshuo Yang; Jianhua Liu; Qingqing Huang; Zhouji Zhang; Jiawei Zhang; Yanjia Pan; Yunke Yang; Dengfeng Cheng
Journal:  Onco Targets Ther       Date:  2017-01-11       Impact factor: 4.147

6.  Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.

Authors:  Jia Liu; Ying Zhang; Shulan Sun; Guirong Zhang; Ke Jiang; Peixin Sun; Ye Zhang; Bing Yao; Rui Sui; Yi Chen; Xu Guo; Tao Tang; Ji Shi; Haiyang Liang; Haozhe Piao
Journal:  Oncol Res       Date:  2018-05-24       Impact factor: 5.574

Review 7.  A research update on the antitumor effects of active components of Chinese medicine ChanSu.

Authors:  Jinhao Jia; Jie Li; Qiusheng Zheng; Defang Li
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

8.  Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure.

Authors:  Wei Ren; Zhiqiang Luo; Fulu Pan; Jiali Liu; Qin Sun; Gang Luo; Raoqiong Wang; Haiyu Zhao; Baolin Bian; Xiao Xiao; Qingrong Pu; Sijin Yang; Guohua Yu
Journal:  PeerJ       Date:  2020-10-30       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.